Back to Search Start Over

Fertility-sparing Surgery for Patients with Cervical, Endometrial, and Ovarian Cancers.

Authors :
Kohn JR
Katebi Kashi P
Acosta-Torres S
Beavis AL
Christianson MS
Source :
Journal of minimally invasive gynecology [J Minim Invasive Gynecol] 2021 Mar; Vol. 28 (3), pp. 392-402. Date of Electronic Publication: 2020 Dec 26.
Publication Year :
2021

Abstract

Objective: Nearly 10% of the 1.3 million women living with a gynecologic cancer are aged <50 years. For these women, although their cancer treatment can be lifesaving, it's also life-altering because traditional surgical procedures can cause infertility and, in many cases, induce surgical menopause. For appropriately selected patients, fertility-sparing options can reduce the reproductive impact of lifesaving cancer treatments. This review will highlight existing recommendations as well as innovative research for fertility-sparing treatment in the 3 major gynecologic cancers.<br />Tabulation, Integration, and Results: For early-stage cervical cancers, fertility-sparing surgeries include cold knife conization, simple hysterectomy with ovarian preservation, or radical trachelectomy with placement of a permanent cerclage. In locally advanced cervical cancer, ovarian transposition before radiation therapy can help preserve ovarian function. For endometrial cancers, fertility-sparing treatment includes progestin therapy with endometrial sampling every 3 to 6 months. After cancer regression, progestin therapy can be halted to allow attempts to conceive. Hysterectomy with ovarian preservation can also be considered, allowing for fertility using assisted reproductive technology and a gestational carrier. For ovarian cancers, fertility-sparing surgery includes unilateral salpingo-oophorectomy or bilateral salpingo-oophorectomy (with lymphadenectomy and staging depending on tumor histology). With higher-risk histology or higher early-stage disease, adjuvant chemotherapy is recommended-however, this carries a 3% to 10% risk of ovarian failure. Use of oocyte or embryo cryopreservation in patients with early-stage ovarian malignancy remains an area of ongoing research.<br />Conclusion: Overall, fertility-sparing management of gynecologic cancers is associated with acceptable rates of progression-free survival and overall survival and is less life-altering than more radical surgical approaches.<br /> (Copyright © 2021 AAGL. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1553-4669
Volume :
28
Issue :
3
Database :
MEDLINE
Journal :
Journal of minimally invasive gynecology
Publication Type :
Academic Journal
Accession number :
33373729
Full Text :
https://doi.org/10.1016/j.jmig.2020.12.027